Transcranial sonography findings related to non-motor features of Parkinson's disease
暂无分享,去创建一个
[1] I. McKeith,et al. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging , 2005, Movement disorders : official journal of the Movement Disorder Society.
[2] Uwe Walter,et al. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. , 2007, Brain : a journal of neurology.
[3] D. Dressler,et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy , 2004, Neurology.
[4] J. Jeng,et al. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[5] H. Miwa,et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. , 2007, Internal medicine.
[6] Uwe Walter,et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. , 2007, Ultrasound in medicine & biology.
[7] S. Herpertz,et al. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency , 2009, European Archives of Psychiatry and Clinical Neuroscience.
[8] Uwe Walter,et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. , 2007, Archives of neurology.
[9] M Kaps,et al. Transcranial Color‐Coded Duplex Sonography of Intracerebral Hematomas in Adults , 1993, Stroke.
[10] U. Bogdahn,et al. Echogenicity of the brainstem raphe in patients with major depression , 1994, Psychiatry Research: Neuroimaging.
[11] Daniela Berg,et al. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings , 2001, Journal of Neurology.
[12] G Becker,et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.
[13] U. Bogdahn,et al. Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. , 1992, Neurosurgery.
[14] W. Lee,et al. Midbrain transcranial sonography in Korean patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[15] Petr Hlustík,et al. Hyperechogenicity of the Substantia Nigra in Parkinson's Disease , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[16] A. Krone,et al. Reliability of transcranial colour-coded real-time sonography in assessment of brain tumours: correlation of ultrasound, computed tomography and biopsy findings , 1994, Neuroradiology.
[17] D. Grimes,et al. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material , 2004, Acta Neuropathologica.
[18] D. Aarsland,et al. A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[19] S. Herpertz,et al. Relationship of brainstem raphe echogenicity and clinical findings in depressive states , 2007, Psychiatry Research: Neuroimaging.
[20] Daniela Berg,et al. Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[21] R. Benecke,et al. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease , 2002, Journal of Neural Transmission.
[22] D. Dressler,et al. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia , 2006, Journal of Neurology.
[23] W. C. Groat. Influence of central serotonergic mechanisms on lower urinary tract function , 2002 .
[24] Uwe Walter,et al. Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes , 2003 .
[25] Uwe Walter,et al. Transcranial sonography in movement disorders , 2008, The Lancet Neurology.
[26] J. Sweeney,et al. Decreased caudate volume in neuroleptic-naive psychotic patients. , 1998, The American journal of psychiatry.
[27] G Becker,et al. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. , 2001, The international journal of neuropsychopharmacology.
[28] D. Berg,et al. Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[29] D. Dressler,et al. Overactive bladder in Parkinson's disease: alteration of brainstem raphe detected by transcranial sonography , 2006, European journal of neurology.
[30] Petra Bártová,et al. Reproducibility of sonographic measurement of the substantia nigra. , 2007, Ultrasound in medicine & biology.
[31] A. Hout,et al. Dementia and survival in Parkinson disease , 2008, Neurology.
[32] K. Gwinn‐Hardy,et al. Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group , 2007, Movement disorders : official journal of the Movement Disorder Society.
[33] C. Fowler,et al. Bladder dysfunction in Parkinsonism: Mechanisms, prevalence, symptoms, and management , 2006, Movement disorders : official journal of the Movement Disorder Society.
[34] G Becker,et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.
[35] D. Aarsland,et al. A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[36] D. Berg,et al. Lesion pattern in patients with multiple sclerosis and depression , 2000, Multiple sclerosis.
[37] P. Falkai,et al. MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls , 2004, Psychiatry Research: Neuroimaging.
[38] R. Pehrson,et al. CNS Involvement in Overactive Bladder , 2012, Drugs.
[39] Daniela Berg,et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. , 2002, Archives of neurology.
[40] Florian Doepp,et al. Brain parenchyma sonography and 123I‐FP‐CIT SPECT in Parkinson's disease and essential tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.
[41] D. Dressler,et al. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[42] Thomas Hummel,et al. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT , 2004, Movement disorders : official journal of the Movement Disorder Society.
[43] U. Bogdahn,et al. Reduced echogenicity of brainstem raphe specific to unipolar depression: A transcranial color-coded real-time sonography study , 1995, Biological Psychiatry.
[44] D. Berg,et al. Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker , 2009, Neurotoxicity Research.
[45] M N Smolka,et al. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study , 2008, Molecular Psychiatry.
[46] Werner Poewe,et al. Midbrain sonography in patients with essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.
[47] Uwe Walter,et al. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: A phantom study , 2008, NeuroImage.
[48] Daniela Berg,et al. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy , 2001, Biological Psychiatry.
[49] Matthias Reimold,et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study , 2008, The Lancet Neurology.
[50] D. Dressler,et al. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease , 2005, Neurology.
[51] H. Reichmann,et al. Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography , 1997, Journal of neurology, neurosurgery, and psychiatry.
[52] G Becker,et al. Relationship of substantia nigra echogenicity and motor function in elderly subjects , 2001, Neurology.
[53] W. Steers,et al. Alterations in Voiding Frequency and Cystometry in the Clomipramine Induced Model of Endogenous Depression and Reversal With Fluoxetine , 2003 .
[54] D. Berg,et al. Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging , 1999, Journal of Neurology.
[55] Christine Klein,et al. Brain parenchyma sonography detects preclinical parkinsonism , 2004, Movement disorders : official journal of the Movement Disorder Society.